与Sjögren综合征相关的NMDAR自身免疫脑炎
Neeraj Kumar1, Devarakonda Prithvi2, Lalit Jha2
1Anaesthesiology and Critical Care Medicine, AIIMS Patna, Patna, Bihar, India neeraj.jlnmc@gmail.com.
BMJ case reports
|June 27, 2025
概括
与Sjögren一起诊断出N-甲基-D-酸盐 (NMDA) 受体脑炎,一种严重的自身免疫性疾病.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 甲基D-酸盐 (NMDA) 受体脑炎是一种严重的自身免疫神经系统疾病.
- 肖格伦综合征 (SS) 是一种慢性自身免疫性疾病,主要影响外分泌腺.
- 同时发生的NMDA受体脑炎和SS是罕见的,并提出诊断挑战.
研究的目的:
- 报告一种罕见的NMDA受体脑炎和Sjögren综合征同时存在的罕见病例.
- 突出由重叠的中枢神经系统表现引起的诊断复杂性.
- 为了证明成功的管理策略,这组合条件.
主要方法:
- 一个具有相关临床表现的年轻女性的病例报告.
- 诊断工作包括病史,临床检查,生化分析和放射性成像.
- 治疗包括免疫疗法和支持性护理.
主要成果:
- 患者呈现出发烧,感官变化,运动障碍,皮质结膜炎,以及.
- 诊断证实为NMDA受体脑炎和肖格伦综合征.
- 通过免疫疗法和支持性治疗获得成功的管理.
结论:
- NMDA受体脑炎和Sjögren综合征的结合是罕见的.
- 重叠的中枢神经系统症状可能会使诊断复杂化.
- 多学科的管理对于有利的结果至关重要.
相关概念视频
Autoimmune Disorders
679
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
679
Myasthenia Gravis: Overview and Treatment
2.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.0K
Nephrotic Syndrome I : Introduction
33
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
33
Nephrotic Syndrome II : Assessment and Medical Management
24
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
24
Myasthenia Gravis: Diagnostic Tests
1.4K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.4K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
459
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
459


